Clinical trial
5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females
NCT02356107 is registered in ClinicalTrials.gov with Perry Renshaw as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females
- Lead sponsor
- Perry Renshaw
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2015
- Completion date
- August 31, 2016
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.